Search for: "Pfizer, Inc.(Pfizer)"
Results 601 - 620
of 1,516
Sorted by Relevance
|
Sort by Date
15 May 2021, 6:00 pm
Bashar Malkawi: Royalty Rate Determination in Patent Infringement Cases: The U.S. and China Compared (Source: SSRN) New Job Postings on Patently-O: Boston Scientific Clark+Elbing LLP Warner Norcross + Judd LLP – Patent Associate Attorney Warner Norcross + Judd LLP – Patent Agent Weaver Austin Villeneuve & Sampson LLP Murphy, Bilak & Homiller PLLC (MBH) McNeill Baur Faegre Drinker ALG Intellectual Property, LLC PTC Therapeutics Inc Miller & Martin Workman… [read post]
4 Feb 2021, 1:17 pm
Here are the nominees along links to any information published on the Ombuds Blog:Roy Baroff, CO-OP (incumbent) — Faculty & Staff Ombuds, North Carolina State University;Suzanne Diviney, CO-OP (incumbent) — Vice President, Office of the Ombuds Lead, Pfizer Inc. [read post]
6 Jan 2014, 6:45 am
(TEVA) of Petach Tikva, Israel, and Pfizer(PFE) Inc. of New York are working with stem-cell researchers on new therapies. [read post]
20 Jan 2008, 10:42 pm
Chantix is classed as a selective nicotinic acetylcholine receptor partial agonist, and is the first smoking cessation drug that is not based on nicotine to come out in the last 10 years.Pfizer Inc. strengthened the warning for iChantix recently, and warned medical professionals to be on the lookout for for abnormal behavior after the shooting death of a rock musician using the drug led to added reports of side effects.A possible link between the drug and reports of agitation, depressed… [read post]
31 Jul 2011, 10:35 pm
Director, Emerging Markets Policy – Pfizer Inc., New York, NYDirector/ Sr. [read post]
11 Jun 2007, 3:43 am
(order) (06/08/2007, non-precedential): Mylan moved for summary reversal of the judgment and amended judgment of the district court, of which Pfizer opposes; in a separate case (Pfizer, Inc. v. [read post]
8 Nov 2010, 7:35 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
10 May 2010, 10:37 am
Quigg, 8 U.S.P.Q.2d 1491 (D.D.C.1988), aff’d 876 F.2d 99 U.S.P.Q.2d 1869 (Fed.Cir.1989), and Pfizer Inc. v. [read post]
3 Feb 2009, 4:23 am
Pfizer, Inc., Docket Nos. 05-4863-cv (L), 05-6768-cv (CON), slip op. (2d Cir. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/23: Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company, LLC v. [read post]
7 Jul 2010, 9:36 am
Pfizer, Inc., 2010 U.S. [read post]
21 Jul 2009, 5:00 am
AXCELIS TECHNOLOGIES, INC., a case involving the invocation of inspection rights to investigate the reasons why the board of directors of Axcelis did not accept the resignation of three directors who failed to receive majority support from shareholders voting in the eleciton. [read post]
10 May 2009, 4:00 pm
Following the example of Pfizerâ€â [read post]
28 Sep 2009, 9:21 am
Axcelis Technologies, Inc., C.A. 4473-VCN (September 28, 2009). [read post]
26 Nov 2012, 4:00 am
Trent Horne and Edward (Ted) Yoo In a unanimous decision, the Supreme Court of Canada has provided valuable guidance to patent agents and litigators as to how Canadian patents will be read and enforced (Teva Canada Limited v Pfizer Canada Inc, 2012 SCC 60). [read post]
2 Jan 2020, 9:25 am
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
7 Aug 2020, 9:15 am
A copy of the Opinion is attached. [1] Plaintiffs, Bristol-Myers Squibb Company and Pfizer Inc., had originally filed the action against at least twenty-five (25) defendant pharmaceutical companies. [read post]
10 Mar 2024, 7:51 am
Pfizer Inc., 646 F. [read post]
7 Sep 2005, 7:25 pm
But the medication, to be marketed by Pfizer Inc., poses safety concerns. [read post]
8 Mar 2012, 5:37 pm
The agency released its safety analysis ahead of a public meeting next week where outside experts will discuss the drugs' safety.Pfizer halted studies of its experimental injection tanezumab in patients with osteoarthritis, low back pain and diabetic nerve pain.On Monday, Pfizer Inc., Johnson & Johnson and Regeneron Pharmaceuticals will make their case to continue studies of the drugs, with new safety precautions to protect patients. [read post]
